Once more, Ding et al. did not distinguish between esophageal adenocarcinoma and esophageal squamous cell carcinoma [26], thus limiting the interpretability of their findings regarding the rate of ASS1 loss and its implications for patient survival in patients with esophageal adenocarcinoma. Here, ASS1 is linked to esophageal squamous cell carcinoma.